A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in the Treatment of Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies

Condition:   Cervical Cancer Interventions:   Drug: BL-B01D1;   Drug: SI-B003 Sponsor:   Sichuan Baili Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials